Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...
PyroGenesis Inc. (“PyroGenesis”) ( (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, ...
Altair (Nasdaq: ALTR), a global leader in computational intelligence, is pleased to announce Future.Industry 2025, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback